Prudential PLC Amgen Inc Transaction History

Prudential PLC

$14.3 Billion
Q2 2024

A detailed history of Prudential PLC transactions in Amgen Inc stock. As of the latest transaction made, Prudential PLC holds 69,981 shares of AMGN stock, worth $22.1 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares

69,981

Previous 65,252 7.25%

Holding current value

$22.1 Million

Previous $18.6 Million 17.86%

% of portfolio

0.15%

Previous 0.15%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 06, 2024	BUY	$262.75 - $319.31 $1.24 Million - $1.51 Million	4,729 Added 7.25%	69,981 $21.9 Million
Q1 2024 May 14, 2024	BUY	$268.87 - $324.56 $6.48 Million - $7.82 Million	24,109 Added 58.6%	65,252 $18.6 Million
Q4 2023 Feb 13, 2024	BUY	$255.7 - $288.46 $56,765 - $64,038	222 Added 0.54%	41,143 $11.9 Million
Q3 2023 Nov 09, 2023	SELL	$218.65 - $271.46 $823,654 - $1.02 Million	-3,767 Reduced 8.43%	40,921 $11 Million
Q2 2023 Aug 14, 2023	SELL	$214.27 - $253.37 $2.63 Million - $3.11 Million	-12,259 Reduced 21.53%	44,688 $9.92 Million
Q1 2023 May 12, 2023	BUY	$225.79 - $275.2 $827,520 - $1.01 Million	3,665 Added 6.88%	56,947 $13.8 Million
Q4 2022 Feb 08, 2023	BUY	$229.03 - $291.01 $4.17 Million - $5.3 Million	18,217 Added 51.95%	53,282 $14 Million
Q3 2022 Nov 14, 2022	BUY	$224.46 - $253.15 $1.19 Million - $1.34 Million	5,305 Added 17.83%	35,065 $7.9 Million
Q2 2022 Aug 12, 2022	SELL	$230.71 - $256.74 $1.25 Million - $1.39 Million	-5,399 Reduced 15.36%	29,760 $7.24 Million
Q1 2022 May 13, 2022	SELL	$219.27 - $242.57 $3.15 Million - $3.48 Million	-14,350 Reduced 28.98%	35,159 $8.5 Million
Q4 2021 Feb 11, 2022	BUY	$198.88 - $227.6 $2.49 Million - $2.85 Million	12,512 Added 33.82%	49,509 $11.1 Million
Q3 2021 Nov 10, 2021	SELL	$212.27 - $248.7 $6.06 Million - $7.1 Million	-28,535 Reduced 43.54%	36,997 $7.87 Million
Q2 2021 Aug 13, 2021	SELL	$233.58 - $259.14 $46.8 Million - $51.9 Million	-200,247 Reduced 75.34%	65,532 $16 Million
Q1 2021 May 14, 2021	SELL	$221.91 - $258.6 $5.15 Million - $6 Million	-23,213 Reduced 8.03%	265,779 $66.1 Million
Q4 2020 Feb 08, 2021	SELL	$216.38 - $257.67 $17 Million - $20.3 Million	-78,755 Reduced 21.42%	288,992 $66.4 Million
Q3 2020 Oct 30, 2020	BUY	$234.65 - $260.95 $4.14 Million - $4.6 Million	17,647 Added 5.04%	367,747 $93.5 Million
Q2 2020 Jul 31, 2020	SELL	$197.81 - $242.74 $29,671 - $36,411	-150 Reduced 0.04%	350,100 $82.6 Million
Q1 2020 May 01, 2020	SELL	$182.24 - $241.7 $36.4 Million - $48.3 Million	-199,638 Reduced 36.31%	350,250 $71 Million
Q4 2019 Feb 13, 2020	SELL	$189.21 - $243.2 $24.1 Million - $31 Million	-127,606 Reduced 18.84%	549,888 $133 Million
Q3 2019 Nov 13, 2019	SELL	$174.11 - $208.62 $39.9 Million - $47.8 Million	-228,903 Reduced 25.25%	677,494 $131 Million
Q2 2019 Aug 14, 2019	BUY	$166.7 - $195.41 $11.7 Million - $13.7 Million	70,273 Added 8.4%	906,397 $167 Million
Q1 2019 May 13, 2019	SELL	$180.87 - $203.88 $12.3 Million - $13.9 Million	-67,933 Reduced 7.51%	836,124 $159 Million
Q4 2018 Feb 13, 2019	SELL	$178.4 - $208.25 $12.3 Million - $14.3 Million	-68,720 Reduced 7.06%	904,057 $176 Million
Q3 2018 Nov 14, 2018	SELL	$185.29 - $208.89 $28.9 Million - $32.6 Million	-155,991 Reduced 13.82%	972,777 $202 Million
Q2 2018 Aug 14, 2018	BUY	$166.05 - $186.51 $1.77 Million - $1.98 Million	10,636 Added 0.95%	1,128,768 $208 Million
Q1 2018 May 15, 2018	BUY	$169.43 - $198.0 $2.93 Million - $3.42 Million	17,281 Added 1.57%	1,118,132 $191 Million
Q4 2017 Feb 14, 2018	BUY	$168.79 - $188.59 $15.9 Million - $17.7 Million	93,988 Added 9.33%	1,100,851 $191 Million
Q3 2017 Nov 14, 2017	SELL	$167.29 - $191.0 $6.01 Million - $6.86 Million	-35,905 Reduced 3.44%	1,006,863 $188 Million
Q2 2017 Aug 14, 2017	BUY	N/A	1,042,768	1,042,768 $180 Million

Others Institutions Holding AMGN

# of Institutions

3,073

Shares Held

417M

Call Options Held

7.19M

Put Options Held

6.28M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Prudential PLC, based on Form 13F filings with the SEC.

News

Stay updated on Prudential PLC with notifications on news.

Account